Crinetics Pharmaceuticals, Inc. (CRNX)
34.78
+0.08
(+0.23%)
USD |
NASDAQ |
May 19, 15:44
Crinetics Pharmaceuticals EPS Diluted (TTM) : -5.133 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Amneal Pharmaceuticals, Inc. | 0.373 |
| Aquestive Therapeutics, Inc. | -0.603 |
| Merck & Co., Inc. | 3.553 |
| Nektar Therapeutics | -8.420 |
| Prestige Consumer Healthcare, Inc. | 3.911 |